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We identified all known cases of malignancy among
HIV-infected patients admitted to the AIDS Center hos-
pital in Saint Petersburg in 2004-2009 via statistical
cards completed for each discharged or dying case with
a final clinical and/or autopsy diagnosis. From a total of
19,410 patients admitted during this period, we identi-
fied 38 cases (0.2%). We randomly selected 42 patients
without malignancy, also using statistical cards. The
cancer cases included 15 (39.5%) AIDS-defining malig-
nancies (ADMs) (9 cases of non-Hodgkin’sl y m p h o m a
[including one case of brain lymphoma], 3 cases of
Kaposi’s sarcoma, and 2 cases of invasive cervical can-
cer), and 23 (60.5%) non-ADMs [Hodgkin’s disease
(7 cases), lung cancer (3 cases), breast, rectal, larynx,
and brain cancer (2 cases each), oral, stomach and penis
cancer (1 case each), and cancer of unknown primary
site (2 cases)]. All cases were confirmed histologically;
the two brain tumors were diagnosed as oligodendro-
glioma and ependymoma.
Most of the cancer patients were men (73.7%), consis-
tent with the population of patients visiting the AIDS
Center. Most cases were diagnosed when patients
sought medical care for cancer-related symptoms. About
60% of the subjects with malignancy died. Patients with
ADMs were younger and had lower CD4 cell counts
and lower HIV RNA loads than those with non-ADMs.
There was no significant difference between the two
groups in (a) the interval between HIV diagnosis and
development of malignancy, (b) cancer survival, (c) HIV
survival, and (d) frequency of death. The majority (55%)
of the patients had stage III-IV malignancies; over half
of the ADM cases and about one-third of non-ADM
cases were untreated. When comparing patients who
had malignancy with those who had no cancer, the
latter were younger, less likely drug users and smokers,
and had higher CD4 cell counts and lower frequency of
death.
Conclusion
The small number of malignancies we identified sug-
gests that malignancies, especially ADMs, in HIV-
infected patients are under-diagnosed in Saint Peters-
burg. The majority of cancers were diagnosed at their
end stages, and almost half of cancers remained
untreated. Patients with malignancy had more risk fac-
tors and a more severe clinical picture than those with
no malignancy. It is imperative that we conduct further
research on malignancies in HIV-infected persons in
Saint Petersburg, with a focus on determining whether
under-diagnosis is occurring and, if so, reasons for
under-diagnosis. Programs to enhance cancer screening
interventions in HIV-infected patients in Saint Peters-
burg may be needed.
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